despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. .
-
.
-
.logout
884 Used Today
318 Used Today
254 Used Today
77 Used Today
110 Used Today
273 Used Today
323 Used Today
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. .
218 Used Today